F7 and hemophilia: Actually, exogenous recombinant activated coagulation factor VII (F7), as an adjunctive therapy, can successfully help to urgently stop internal bleeding caused by acquired hemophilia as an autoimmune complication of RA, which is treated with immunosuppressive therapy at the same time (Drobiecki et al., 2013).